Anna Pagonakis

Array ( [id] => 4989481 [patent_doc_number] => 20070155822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'USE OF BENZO-FUSED HETEROCYCLE SULFAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN' [patent_app_type] => utility [patent_app_number] => 11/612071 [patent_app_country] => US [patent_app_date] => 2006-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18816 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20070155822.pdf [firstpage_image] =>[orig_patent_app_number] => 11612071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4989482 [patent_doc_number] => 20070155823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'USE OF BENZO-FUSED HETEROCYCLE SULFAMIDE DERIVATIVES AS NEUROPROTECTIVE AGENTS' [patent_app_type] => utility [patent_app_number] => 11/612146 [patent_app_country] => US [patent_app_date] => 2006-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12452 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20070155823.pdf [firstpage_image] =>[orig_patent_app_number] => 11612146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4989483 [patent_doc_number] => 20070155824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'USE OF BENZO-FUSED HETEROCYCLE SULFAMIDE DERIVATIVES FOR DISEASE MODIFICATION / EPILEPTOGENESIS' [patent_app_type] => utility [patent_app_number] => 11/612174 [patent_app_country] => US [patent_app_date] => 2006-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20029 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20070155824.pdf [firstpage_image] =>[orig_patent_app_number] => 11612174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5189113 [patent_doc_number] => 20070167422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Pharmaceutical compositions comprising 17-allylamino-17-demethoxygeldanamycin' [patent_app_type] => utility [patent_app_number] => 11/637566 [patent_app_country] => US [patent_app_date] => 2006-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5166 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20070167422.pdf [firstpage_image] =>[orig_patent_app_number] => 11637566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6495281 [patent_doc_number] => 20100093804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => ' NOVEL CRYSTALLINE FORM OF LANSOPRAZOLE' [patent_app_type] => utility [patent_app_number] => 11/993960 [patent_app_country] => US [patent_app_date] => 2006-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1431 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093804.pdf [firstpage_image] =>[orig_patent_app_number] => 11993960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792764 [patent_doc_number] => 20080293738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Formulation of Quinolinones' [patent_app_type] => utility [patent_app_number] => 12/094806 [patent_app_country] => US [patent_app_date] => 2006-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20743 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293738.pdf [firstpage_image] =>[orig_patent_app_number] => 12094806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6496130 [patent_doc_number] => 20100286090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Treatment of Multiple Myeloma' [patent_app_type] => utility [patent_app_number] => 12/084657 [patent_app_country] => US [patent_app_date] => 2006-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 1138 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286090.pdf [firstpage_image] =>[orig_patent_app_number] => 12084657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4833984 [patent_doc_number] => 20080132531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'SYNERGISTIC COMBINATIONS OF NORKETAMINE AND OPIOID ANALGESICS' [patent_app_type] => utility [patent_app_number] => 11/558782 [patent_app_country] => US [patent_app_date] => 2006-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 10986 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20080132531.pdf [firstpage_image] =>[orig_patent_app_number] => 11558782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368612 [patent_doc_number] => 20090306171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'INDOLE COMPOUNDS HAVING C4-AMIDE SUBSTITUENTS AND USE THEREOF AS PHOSPHOLIPASE-A2 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/092388 [patent_app_country] => US [patent_app_date] => 2006-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 32479 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306171.pdf [firstpage_image] =>[orig_patent_app_number] => 12092388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5398429 [patent_doc_number] => 20090318492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'INDOLE COMPOUNDS HAVING C4-ACIDIC SUBSTITUENTS AND USE THEREOF AS PHOSPHOLIPASE-A2 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/092380 [patent_app_country] => US [patent_app_date] => 2006-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 42211 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318492.pdf [firstpage_image] =>[orig_patent_app_number] => 12092380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146758 [patent_doc_number] => 08163770 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Benzoxathiin derivative' [patent_app_type] => utility [patent_app_number] => 12/084017 [patent_app_country] => US [patent_app_date] => 2006-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47728 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163770.pdf [firstpage_image] =>[orig_patent_app_number] => 12084017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6629013 [patent_doc_number] => 20100004248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'Use of a Nitric Oxide Synthase Modulator for the Treatment of Cardiac Indications' [patent_app_type] => utility [patent_app_number] => 12/084165 [patent_app_country] => US [patent_app_date] => 2006-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 21029 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004248.pdf [firstpage_image] =>[orig_patent_app_number] => 12084165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5265586 [patent_doc_number] => 20090118271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Preventive or Therapeutic Agents for Pancreatic Cancer, Ovarian Cancer, or Liver Cancer Comprising a Novel Water-Soluble Prodrug \n' [patent_app_type] => utility [patent_app_number] => 12/083831 [patent_app_country] => US [patent_app_date] => 2006-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25970 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20090118271.pdf [firstpage_image] =>[orig_patent_app_number] => 12083831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4977951 [patent_doc_number] => 20070219184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Method of increasing thymic output in HIV-negative patients by treatment with antiretroviral agents' [patent_app_type] => utility [patent_app_number] => 11/580359 [patent_app_country] => US [patent_app_date] => 2006-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4282 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20070219184.pdf [firstpage_image] =>[orig_patent_app_number] => 11580359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4664264 [patent_doc_number] => 20080255171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Combination of Nilotinib with Farnesyl Transferase Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/089317 [patent_app_country] => US [patent_app_date] => 2006-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4867 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20080255171.pdf [firstpage_image] =>[orig_patent_app_number] => 12089317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4697812 [patent_doc_number] => 20080219996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'Molecular Markers Associated with Bone Metastasis' [patent_app_type] => utility [patent_app_number] => 12/066412 [patent_app_country] => US [patent_app_date] => 2006-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7723 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20080219996.pdf [firstpage_image] =>[orig_patent_app_number] => 12066412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5057710 [patent_doc_number] => 20070060632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Lofexidine' [patent_app_type] => utility [patent_app_number] => 11/517565 [patent_app_country] => US [patent_app_date] => 2006-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5996 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20070060632.pdf [firstpage_image] =>[orig_patent_app_number] => 11517565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4740696 [patent_doc_number] => 20080234349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'PPAR active compounds' [patent_app_type] => utility [patent_app_number] => 11/517010 [patent_app_country] => US [patent_app_date] => 2006-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31132 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20080234349.pdf [firstpage_image] =>[orig_patent_app_number] => 11517010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4644442 [patent_doc_number] => 08022047 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-20 [patent_title] => 'Combination anticancer agents' [patent_app_type] => utility [patent_app_number] => 12/064352 [patent_app_country] => US [patent_app_date] => 2006-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 28340 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/022/08022047.pdf [firstpage_image] =>[orig_patent_app_number] => 12064352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5023652 [patent_doc_number] => 20070149618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis' [patent_app_type] => utility [patent_app_number] => 11/506469 [patent_app_country] => US [patent_app_date] => 2006-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 11976 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20070149618.pdf [firstpage_image] =>[orig_patent_app_number] => 11506469 [rel_patent_id] =>[rel_patent_doc_number] =>)